Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-007887 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-08 | 2022-02-07 | ALXO | GARCIA PETER S | CFO | M - OptEx | $4.49 | +15.0K | 16.1K | +1,339% | +$67.3K |
| DM | 2022-02-08 | 2022-02-07 | ALXO | GARCIA PETER S | CFO | M - OptEx | $0.00 | -15.0K | 20.8K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | M | A | 8,363 | $4.81 | 24,483 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-07 | M | A | 6,637 | $4.08 | 16,120 | D | — | — | (F1) Includes 152 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-02-07 | M | D | 6,637 | $0.00 | 89,022 | D | $4.08 · — to 2030-03-09 | 6,637 Common Stock | (F2) The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2022-02-07 | M | D | 8,363 | $0.00 | 20,813 | D | $4.81 · — to 2030-04-27 | 8,363 Common Stock | (F4) One-fourth of the shares subject to the option vest on April 27, 2021 and 1/36th of the remaining shares vest monthly thereafter. |